Related Experiment Videos
Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK
Lynn T Singer1, Derek G Moore2, Meeyoung O Min1
1Case Western Reserve University, Cleveland, Ohio, USA.
Insights
Prenatal exposure to methylenedioxymethamphetamine (MDMA, "ecstasy") is linked to motor delays in infants. Higher MDMA exposure correlated with greater motor deficits up to 12 months.
Area of Science:
- Developmental Pediatrics
- Neuroscience
- Obstetrics
Background:
- Prenatal exposure to recreational drugs, including methylenedioxymethamphetamine (MDMA, "ecstasy"), may impact infant development.
- Understanding the long-term effects of prenatal MDMA exposure is crucial for public health and clinical guidance.
Purpose of the Study:
- To examine the effects of prenatal methylenedioxymethamphetamine (MDMA) exposure on infant development from birth to two years.
- To investigate the relationship between the amount of MDMA exposure and developmental outcomes.
Main Methods:
- A prospective, longitudinal cohort study followed 28 MDMA-exposed and 68 non-exposed infants.
- Maternal interviews collected data on drug use during pregnancy, controlling for covariates.
- Infants underwent standardized developmental assessments at 1, 4, 12, 18, and 24 months.
Main Results:
- No significant differences were observed at birth, though MDMA-exposed infants were more likely to be male.
- Motor delays were consistently observed in MDMA-exposed infants.
- A dose-dependent relationship was found between MDMA exposure and motor deficits at 12 months.
Conclusions:
- Prenatal MDMA exposure is associated with fine and gross motor delays in early childhood.
- Further research is necessary to ascertain the long-term developmental consequences of prenatal MDMA exposure.
Objective:
This paper aims to review findings from a longitudinal study of prenatal methylenedioxymethamphetamine (MDMA, "ecstasy") on infant development.
Methods:
In a prospective, longitudinal cohort design, we followed 28 MDMA-exposed and 68 non-MDMA-exposed infants from birth to 2 years of age. Women recruited voluntarily into a study of recreational drug use during pregnancy were interviewed to obtain type, frequency, and amount of recreational drug use. Their children were followed for a 2-year period after birth. A large number of drug and environmental covariates were controlled. Infants were seen at 1, 4, 12, 18, and 24 months using standardized normative tests of mental and motor development.
Results:
There were no differences between MDMA-exposed and non-MDMA-exposed infants at birth except that MDMA-exposed infants were more likely to be male. Motor delays were evident in MDMA infants at each age and amount of MDMA exposure predicted motor deficits at 12 months in a dose-dependent fashion.
Conclusions:
Prenatal MDMA exposure is related to fine and gross motor delays in the first 2 years of life. Follow-up studies are needed to determine long-term effects.